Now, a common asthma drug promises to help delay rare heart complications

A common asthma drug has the potential to help delay development of a rare heart complication that lacks effective drug treatment, according to researchers. Aortic aneurysm — the dilation of the aorta — is a serious condition that occurs when the wall of the aorta, the body’s largest artery, weakens […]

Moms-to-be, taking this epilepsy drug during pregnancy increases risk of oral cleft in baby

Women taking a common anti-epileptic drug during early pregnancy may have a greater chance of giving birth to a baby with an oral cleft, warns a new study. “Our results suggest that the increased risk of oral clefts is most pronounced in women taking higher doses of topiramate to treat […]

Natco Pharma’s Partner Mylan Inc Gets USFDA Approval For Cancer Drug

Mylan Inc has received a tentative approval from the USFDA for abbreviated new drug application for Sorafenib tablets in the strength of 200 mg. New Delhi: Natco Pharma on Friday said its marketing partner Mylan Inc has received tentative approval from the US health regulator for selling generic Sorafenib tablets used […]

Cipla completes $550 million acquisition of 2 US generic drug companies

Cipla has compled its $ 550-million (around Rs 3575 crore) acquisition of US generic drug makers InvaGen and Exelan. This gives the 80-year-old Indian drug maker a bigger presence in the lucrative US market. This is its second major acquisition after the Rs 2,700-crore deal to buy South African drug […]